After enduring almost nine months of COVID-19 in the United States, it seems as if a vaccine may not be far away. On Nov. 9, the biopharmaceutical company Pfizer and the biotech company BioNTech announced that their vaccine candidate was more than 90 percent effective in phase three trials. The…
Read More